Cancer Pathophysiology
A section of Cancers (ISSN 2072-6694).
Section Information
The major abnormality driving the development of all cancer types is the dysregulated proliferation of cancer cells that grow and divide in an uncontrolled manner, invading normal tissues and organs and eventually spreading throughout the body. Such loss of control in growth is the net result of the accumulation of abnormalities in diverse regulatory systems, resulting in such modifications of cell behavior that distinguish cancerous from normal cells.
Cancer development has historically been seen as a multistep process involving mutation and selection for cells with a progressively increasing capacity for proliferation, survival, invasion, and metastasis. The first step in this process, referred to as tumor initiation, is considered to result from a genetic alteration leading to abnormal proliferation and the generation of a population of clonally derived tumor cells. Further mutations progressively accumulate and are responsible for tumor progression, which confers the so-called property of clonal selection that continues throughout tumor development.
In parallel, more recent findings indicate that epigenetic changes as well as alterations in the noncoding RNA repertoire may occur and significantly contribute to both the initiation and progression of cancer.
This section of Cancers aims to publish contributions on all aspects of cancer pathophysiology. We encourage the submission of all types of manuscripts, including original articles, narrative and systematic reviews, and communications reporting significant advances in the pathophysiology of solid and hematologic cancers. Topics include, but are not limited to:
- Cancer biology
- Cancer dependency
- Cancer epigenetics
- Cancer phenotype
- Cancer genetics
- Cancer-associated miRNAs
- Cancer stem cells
- Cancer translational research
- Cancer-associated noncoding RNAs
- DNA damage
- DNA repair systems
- Hematological cancers
- Metastasis
- Oncogenes
- Pre-malignant conditions
- Signal transduction pathways
- Solid cancers
- Targeted anticancer therapy
- Tumor angiogenesis
- Tumor differentiation
- Tumor suppressor genes
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Clinico-Pathological, Dermoscopic and Genetic Analyses in Melanoma: Different Diagnostic Processes for an Early and Accurate Detection of Melanoma (Deadline: 25 September 2023)
- Oncogenes in Cancer 2.0 (Deadline: 30 September 2023)
- Advances in Cervical Cancer: From Pathogenesis to Therapy (Deadline: 30 September 2023)
- Cancer and Chronic Illness (Deadline: 30 September 2023)
- Advances in Diagnosis and Differentiation in Head and Neck and Neuro Oncology (Deadline: 30 September 2023)
- Molecular and Cellular Changes in the Formation of Tumor-Initiating Cells (Deadline: 30 September 2023)
- Pathology of Breast Cancer (Deadline: 10 October 2023)
- Genetics of Ovarian Cancer (Deadline: 20 October 2023)
- Prostate Cancer Progression (Deadline: 25 October 2023)
- Basic Research of Hepatopancreatobillary Tumor (Deadline: 31 October 2023)
- Mechanisms of Therapeutic Resistance in Glioblastoma (Deadline: 31 October 2023)
- Pathology of Hematologic Malignancies (Deadline: 31 October 2023)
- Molecular Pathology of Glioma (Deadline: 31 October 2023)
- Pathology and Genetics of Glioblastoma (Deadline: 10 November 2023)
- Urogenital Neoplasms Pathology (Deadline: 10 November 2023)
- Lipids and Small Metabolites in Cancer (Deadline: 10 November 2023)
- New Developments in the Treatment of Early-Stage and Advanced Melanoma (Deadline: 30 November 2023)
- Molecular Pathogenesis of Cervical Cancer (Second Edition) (Deadline: 30 November 2023)
- Advances in Neuroendocrine Neoplasms (Deadline: 30 November 2023)
- Stem Cell Origin of Cancers: Biological and Clinical Implications of a Unified Theory of Cancer (Deadline: 5 December 2023)
- Advances in Genomics and Molecular Pathology of Rare Cancers—Focus on Diverse Populations (Deadline: 10 December 2023)
- Wnt Pathway Targets in Cancer (Deadline: 20 December 2023)
- Metabolic Alterations in Cancer (Deadline: 31 December 2023)
- Targeting Cancer Cell Invasion and Metastasis: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 December 2023)
- Actionable Vulnerabilities in Hematological Malignancies (Deadline: 31 December 2023)
- Current Trends in Epigenetics of Brain Tumors: Basic and Translational Research (Deadline: 31 December 2023)
- Pathogenesis, Prognosis and Prediction in Breast Cancer (Deadline: 31 December 2023)
- Redox Mechanism in Infection-Associated Cancers (Deadline: 31 December 2023)
- Interplay between Signaling Pathways and Metabolism in Brain Tumors (Deadline: 31 December 2023)
- The Role of Vitamin D in Cancer (Deadline: 31 December 2023)
- Histology and Pathology of Pancreatic Cancer (Deadline: 16 January 2024)
- Epigenetics and Transcription Networks in Leukemia (Deadline: 31 January 2024)
- Polyphenols and Cancer Metabolism (Deadline: 31 January 2024)
- Pathology of Urogenital Cancers (Deadline: 31 January 2024)
- Pathogenesis of Non-alcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma (HCC) (Deadline: 1 February 2024)
- Genetic, Epigenetic, and Epitranscriptomic Changes in Lung Cancer (Deadline: 29 February 2024)
- Pathogenesis, Diagnostics and Prognostics in Head and Neck Cancer (Deadline: 29 February 2024)
- Endoscopic Ultrasound in Cancer Research (Deadline: 30 March 2024)
- Genetics and Epigenetics of Gynecological Cancer (Deadline: 31 March 2024)
- Pathology of Gynecological Cancers (Deadline: 31 March 2024)
- Updates on Epigenetics of Brain Tumor (Deadline: 5 April 2024)
- Pathology, Diagnosis and Treatment in Non-small Cell Lung Cancer (Deadline: 12 April 2024)
- Melanoma: Pathology and Translational Research (Deadline: 20 April 2024)
- The Role of Tunneling Nanotubes in Intercellular Communication and Pathophysiology of Cancer (Deadline: 25 April 2024)
- Pathology of Acute Myeloid Leukemia (AML) (Deadline: 25 April 2024)
- Hypothalamic Hormones and Cancer (Deadline: 30 April 2024)
- The Role of NPM1 Mutation in Acute Myeloid Leukemia (Deadline: 1 May 2024)
- Molecular Mechanisms and Pathophysiology of Oral Cancer (Deadline: 10 May 2024)
- Oncogenesis of Pancreatic Cancer: Where Are We (Deadline: 15 May 2024)
- Stress Response Pathways in Cancer (Deadline: 31 May 2024)
- Targeting Histone Deacetylases in Cancer (Volume II) (Deadline: 31 May 2024)
- The Role of the Cytoskeleton in Tumor Progression (Deadline: 31 May 2024)
- Advances in Breast Cancer: From Pathogenesis to Therapy (Deadline: 31 May 2024)
- Epigenetic Landscape of Head and Neck Carcinomas (Deadline: 15 June 2024)
- Clinical Applications of Molecular Subtyping of Pancreatic Cancer (Deadline: 1 July 2024)
- Insights on Mechanisms of Cell Death in Cancer Cells (Deadline: 10 July 2024)
- Staging and Pathology of Bladder Cancer (Deadline: 15 July 2024)
- Lymphoma Biology, Pathology and Stem Cells (Deadline: 9 August 2024)
- Fitness, Fate and Opportunities in Cancer Evolution (Deadline: 31 August 2024)
- Pathology of Gynecologic Cancer (Deadline: 5 September 2024)
- Histopathology of Urological Cancers (Deadline: 30 September 2024)
Topical Collections
Following topical collections within this section are currently open for submissions: